Investigating the Role of Cellular Signaling in Liver-Stage Malaria Infection

研究细胞信号传导在肝期疟疾感染中的作用

基本信息

项目摘要

Malaria presents a severe health burden, particularly in the developing world yet no vaccine is currently available. The parasites enter the human host through the bite of the female Anopheles mosquito and first infect liver hepatocytes, before moving to the blood infection that causes all disease. During liver stage development, parasites protect their home in the host hepatocyte by preventing programmed cell death (apoptosis) of the infected cell. Genetically attenuated parasite (GAP) strains that induce sterile immunity in mice have been developed, and it was shown for one of these strains that it cannot control host cell apoptosis. The mechanism of the inhibition of apoptosis by wildtype parasites, however, has not been elucidated. I will first fully delineate the apoptotic phenotype of hepatocytes infected with wildtype parasites and GAPs using a variety of phenotypic assays. Next, I plan to monitor a number of candidate signaling proteins in hepatocytes in response to both wildtype and GAP infections. This will allow us to identify candidate genes that are differentially activated in response to pro-apoptotic attenuated parasites and anti-apoptotic wildtype parasites. Finally, I propose to further investigate candidate genes that are differentially regulated using a cell culture model, as well as immunization and challenge experiments in mice. This study will lead to the discovery of hepatocyte proteins critical to modulating the inhibition of apoptosis by wildtype parasites. Since infected apoptotic cells are a better stimulus for the immune system than surviving cells, inhibiting these host proteins may cause the induction of apoptosis by wildtype parasites and might also enhance immunity induced by live-attenuated vaccines. Altering the hepatocyte response to infection could convert a wildtype, disease promoting parasite into one that promotes protective immunity and might thus inform new intervention strategies at the early stage of malaria infection.
疟疾是一种严重的健康负担,特别是在发展中国家,但目前还没有疫苗。寄生虫通过雌性按蚊的叮咬进入人类宿主,首先感染肝细胞,然后转移到导致所有疾病的血液感染。在肝脏发育阶段,寄生虫通过防止被感染细胞的程序性细胞死亡(凋亡)来保护它们在宿主肝细胞中的家园。基因减毒寄生虫(GAP)在小鼠体内诱导无菌免疫已被开发出来,其中一株被证明不能控制宿主细胞凋亡。然而,野生型寄生虫抑制细胞凋亡的机制尚未阐明。我将首先充分描述肝细胞的凋亡表型感染野生型寄生虫和间隙使用各种表型测定。接下来,我计划监测肝细胞中应对野生型和GAP感染的一些候选信号蛋白。这将使我们能够识别在促凋亡减毒寄生虫和抗凋亡野生型寄生虫反应中差异激活的候选基因。最后,我建议使用细胞培养模型以及小鼠免疫和激发实验进一步研究差异调节的候选基因。这项研究将导致发现对调节野生型寄生虫抑制细胞凋亡至关重要的肝细胞蛋白。由于受感染的凋亡细胞比存活细胞对免疫系统有更好的刺激作用,抑制这些宿主蛋白可能导致野生型寄生虫诱导细胞凋亡,也可能增强减毒活疫苗诱导的免疫力。改变肝细胞对感染的反应可以将一种野生型、促进疾病的寄生虫转化为一种促进保护性免疫的寄生虫,从而可能在疟疾感染的早期阶段为新的干预策略提供信息。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Suppression of host p53 is critical for Plasmodium liver-stage infection.
  • DOI:
    10.1016/j.celrep.2013.02.010
  • 发表时间:
    2013-03-28
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Kaushansky A;Ye AS;Austin LS;Mikolajczak SA;Vaughan AM;Camargo N;Metzger PG;Douglass AN;MacBeath G;Kappe SH
  • 通讯作者:
    Kappe SH
Malaria parasite liver stages render host hepatocytes susceptible to mitochondria-initiated apoptosis.
  • DOI:
    10.1038/cddis.2013.286
  • 发表时间:
    2013-08-08
  • 期刊:
  • 影响因子:
    9
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alexis Kaushansky其他文献

Alexis Kaushansky的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alexis Kaushansky', 18)}}的其他基金

Elucidating host phosphosignaling regulation of Plasmodium vivax liver stage
阐明间日疟原虫肝脏阶段的宿主磷酸信号调节
  • 批准号:
    10056490
  • 财政年份:
    2020
  • 资助金额:
    $ 5.42万
  • 项目类别:
Elucidating host phosphosignaling regulation of Plasmodium vivax liver stage
阐明间日疟原虫肝脏阶段的宿主磷酸信号调节
  • 批准号:
    10170244
  • 财政年份:
    2020
  • 资助金额:
    $ 5.42万
  • 项目类别:
Investigating hepatocyte signaling driven by host-pathogen interactions
研究宿主-病原体相互作用驱动的肝细胞信号传导
  • 批准号:
    8821942
  • 财政年份:
    2015
  • 资助金额:
    $ 5.42万
  • 项目类别:
Investigating hepatocyte signaling driven by host-pathogen interactions
研究宿主-病原体相互作用驱动的肝细胞信号传导
  • 批准号:
    9203313
  • 财政年份:
    2015
  • 资助金额:
    $ 5.42万
  • 项目类别:
Perturbations of host cell signaling by a complex hepatotropic pathogen
复杂的嗜肝病原体对宿主细胞信号传导的干扰
  • 批准号:
    10677933
  • 财政年份:
    2013
  • 资助金额:
    $ 5.42万
  • 项目类别:
Perturbations of host cell signaling by a complex hepatotropic pathogen
复杂的嗜肝病原体对宿主细胞信号传导的干扰
  • 批准号:
    9896827
  • 财政年份:
    2013
  • 资助金额:
    $ 5.42万
  • 项目类别:
Investigating the Role of Cellular Signaling in Liver-Stage Malaria Infection
研究细胞信号传导在肝期疟疾感染中的作用
  • 批准号:
    8001602
  • 财政年份:
    2010
  • 资助金额:
    $ 5.42万
  • 项目类别:
Investigating the Role of Cellular Signaling in Liver-Stage Malaria Infection
研究细胞信号传导在肝期疟疾感染中的作用
  • 批准号:
    8090318
  • 财政年份:
    2010
  • 资助金额:
    $ 5.42万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 5.42万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 5.42万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 5.42万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.42万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 5.42万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 5.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 5.42万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 5.42万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 5.42万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 5.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了